Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.2SEK
−179.67 MSEK
0.00SEK
14.59 M
About XSPRAY PHARMA AB
Sector
CEO
Per Andersson
Headquarters
Solna
Website
Employees (FY)
26
Founded
2003
ISIN
SE0009973563
FIGI
BBG00HL0YGT4
Xspray Pharma AB is a pharmaceutical company, which develops and produces product candidates in clinical development phase. It uses its innovative, patented technology to develop amorphous product candidates that are improved versions of marketed drugs, primarily protein kinase inhibitors, for the treatment of cancer. Its product portfolio includes candidates based on the firm's HyNap platform: Dasynoc, HyNap-Nilo, and HyNap-Sora. The company was founded by Mustafa Demirbüker and Håkan Nykvist in November 2003 and is headquartered in Solna, Sweden.
An aggregate view of professional's ratings.
Frequently Asked Questions
The current price of XSPRAY is 50.6 SEK — it has increased by 10.24% in the past 24 hours. Watch XSPRAY PHARMA AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange XSPRAY PHARMA AB stocks are traded under the ticker XSPRAY.
XSPRAY stock has risen by 1.71% compared to the previous week, the month change is a 0.20% rise, over the last year XSPRAY PHARMA AB has showed a 3.27% increase.
We've gathered analysts' opinions on XSPRAY PHARMA AB future price: according to them, XSPRAY price has a max estimate of 94.00 SEK and a min estimate of 58.00 SEK. Watch XSPRAY chart and read a more detailed XSPRAY PHARMA AB stock forecast: see what analysts think of XSPRAY PHARMA AB and suggest that you do with its stocks.
XSPRAY reached its all-time high on Aug 6, 2020 with the price of 267.0 SEK, and its all-time low was 26.2 SEK and was reached on Oct 11, 2017. View more price dynamics on XSPRAY chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
XSPRAY stock is 18.55% volatile and has beta coefficient of 0.98. Track XSPRAY PHARMA AB stock price on the chart and check out the list of the most volatile stocks — is XSPRAY PHARMA AB there?
Today XSPRAY PHARMA AB has the market capitalization of 1.43 B, it has decreased by −5.75% over the last week.
Yes, you can track XSPRAY PHARMA AB financials in yearly and quarterly reports right on TradingView.
XSPRAY PHARMA AB is going to release the next earnings report on Nov 6, 2024. Keep track of upcoming events with our Earnings Calendar.
XSPRAY earnings for the last quarter are −1.55 SEK per share, whereas the estimation was −1.55 SEK resulting in a 0.00% surprise. The estimated earnings for the next quarter are −1.39 SEK per share. See more details about XSPRAY PHARMA AB earnings.
XSPRAY net income for the last quarter is −53.58 M SEK, while the quarter before that showed −67.74 M SEK of net income which accounts for 20.90% change. Track more XSPRAY PHARMA AB financial stats to get the full picture.
No, XSPRAY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 20, 2024, the company has 26.00 employees. See our rating of the largest employees — is XSPRAY PHARMA AB on this list?
Like other stocks, XSPRAY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XSPRAY PHARMA AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So XSPRAY PHARMA AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating XSPRAY PHARMA AB stock shows the sell signal. See more of XSPRAY PHARMA AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.